<DOC>
	<DOCNO>NCT02152930</DOCNO>
	<brief_summary>Intermittent claudication ( IC ) cause peripheral arterial disease high morbidity mortality . Etiologic factor similar cardiovascular disease . Primary treatment consist cardiovascular risk management improvement functional capacity supervise exercise therapy ( SET ) . A potential additional therapy administration fish oil supplement contain high amount omega-3 Poly Unsaturated Fatty Acids ( PUFAs ) . In earlier clinical experimental trial omega-3 PUFA 's improved hemorheological parameter erythrocyte deformability aggregation , number cardiovascular risk factor . Hemorheological parameter determine blood flow microcirculation , main importance patient IC since macrocirculation compromise . Inflammation consider important etiologic factor pathogenesis atherosclerosis contribute peripheral arterial disease Since omega-3 PUFAs also strong anti-inflammatory effect , might effective patient IC lower inflammatory response . In addition , visceral fat rather obesity general recognise etiologic prognostic factor atherosclerosis . We hypothesise administration omega-3 PUFA 's patient IC synergistic effect SET improve walk distance SET , improve hemorheological parameter result good microcirculation . Second , hypothesise omega-3 PUFA 's result le proinflammatory whole blood response ex vivo stimulation endotoxin . Third , hypothesise omega-3 PUFA 's SET result decrease visceral fat mass .</brief_summary>
	<brief_title>The Effects Fish Oil Supplements During Supervised Exercise Therapy Patients With Intermittent Claudication</brief_title>
	<detailed_description />
	<mesh_term>Intermittent Claudication</mesh_term>
	<criteria>Age â‰¥ 18 Newly diagnose intermittent claudication Ankle Brachial Index &lt; 0.8 rest &gt; 0.15 decrease exercise Able perform standardise treadmill walk test 2 min Written inform consent Unable fill questionnaire ( cognitive impairment insufficient knowledge Dutch language ) Heart failure unstable cardiac status ( angina pectoris class III IV recent myocardial infarction &lt; 3 month ) Any illness rapid evolution life expectancy &lt; 3 month Recent cerebrovascular accident ( &lt; 3 month ) Current use fish oil supplement &gt; 2 time week dietary fish Pregnancy Fish , soybean peanut allergy Contra indication use omega3 fatty acid Use oral anticoagulant ( coumarin derivative )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Fish oil supplement</keyword>
	<keyword>Supervised Exercise Training</keyword>
	<keyword>Walking distance</keyword>
	<keyword>Hemorheological factor</keyword>
	<keyword>Cardiovascular risk</keyword>
</DOC>